NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Register
ADVERTISEMENT
ADVERTISEMENT
The antibody-drug conjugate trastuzumab deruxtecan delays cancer growth for women with hormone receptor-positive (HR+)...
According to a new study presented at the 2024 ASCO Annual Meeting, adding the antibody-drug conjugate...
For patients with locally advanced oesophageal adenocarcinoma that can be treated with surgery, chemotherapy treatment...
Results from a new study presented at the 2024 American Society of Clinical Oncology (ASCO) Annual...
The management of bladder cancer is evolving rapidly, with a new regimen recently approved for patients...
RCSI research has found that venetoclax, a medication currently approved for leukaemia, has benefits for patients...
Testing for tumour DNA in the blood can successfully identify advanced bladder cancer patients who will...
A PSA blood test every five years is sufficient to screen low-risk men for prostate cancer,...
Review aims to implement a more personalised and multidisciplinary approach in treatment of menopause...
The Congressional Caucus heard how a unique partnership has significantly increased both the quality and...
Michelle, a 46-year-old female, underwent biopsy of a lesion in her left sided chest musculature in...
This year’s ISMO meeting heard presentations on a variety of high-quality cancer studies that have taken...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT